Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Mood and Cognition in Nicotine Withdrawal
NCT03593538Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Apr 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in nicotine dependence, sponsored by University of Pennsylvania. Started Apr 2016; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03593538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03593538.